Capricor jumps as study shows longer-term effects of deramiocel

Data ReadoutpositivederamiocelPositive

AI Analysis

Capricor announced positive study results demonstrating longer-term effects of its deramiocel candidate, causing the stock to rise.

Study shows longer-term effects of deramiocel

Importance:5/10

Sentiment:

0.70

data readoutclinical trialpositive data

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 30, 2026 1:24 AM